Innovation
Alsymo aims to treat patients with pulmonary hypertension
… disciplines proved decisive: they came up with the idea of designing N-methyl-D-aspartate (NMDA) receptor antagonists … of the selective NMDAR antagonist drug candidate and the design of clinical trials including, as a priority, the … disciplines proved decisive: they came up with the idea of designing N-methyl-D-aspartate (NMDA) receptor antagonists …Published on: